Post-therapy normalization of brain FDG-PET in Morvan's syndrome.

L Benedetti, D Franciotta, M Zoccarato, A Beronio, M Godani, E Schirinzi, G Siciliano, A Ciarmiello, M Del Sette

Journal: Journal of the neurological sciences 2016;353(1-2):175-6

PMID: 25896288

Full Text on Elsevier Science View on PubMed

Abstract

Address: Department of Neurology, Osp. S. Andrea, La Spezia, Italy. Electronic address: [email protected].; Laboratory of Neuroimmunology, 'C. Mondino' National Neurological Institute, Pavia, Italy.; Department of Neuroscience, University of Padova, Italy.; Department of Neurology, Osp. S. Andrea, La Spezia, Italy.; Department of Clinical and Experimental Medicine, Neurological Clinic, University of Pisa, Pisa, Italy.; Department of Nuclear Medicine, Osp. S. Andrea, La Spezia, Italy.

DOI: 10.1016/j.jns.2015.03.035

Link outs

Free resources

Medical:

https://medlineplus.gov/syringomyelia.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Brain, Fluorodeoxyglucose F18, Humans, Male, Middle Aged, Positron-Emission Tomography, Syringomyelia